Skip to content
Back to Investors
E

EQT

Venture Capital

Investment firm operating a health economics strategy focused on healthcare innovations.


Recent investments

Series B
£47.0M

The Series B round was led by IVP to support expansion into APAC and the Americas.

"Testament to our progress and our vision for real-time payments everywhere, we’re thrilled to be working with our new partners at IVP, joining their portfolio of leading global brands. We’re staying focused, and humble, as we embark on this next chapter."
— Tom Greenwood, CEO
Seed
£3.0M

The Stockholm-founded investor led the financing to help accelerate commercialisation of the firm's carbon capture technology.

"The foundation, formulation, and chemicals industries are some of the world's greatest polluters and many have aimed to reach carbon neutrality by 2050. ViridiCO2 is focused on assisting the chemicals industry to decarbonise by putting the 7 billion tonnes of industry waste CO2 to good use, creating sustainable products, and a new income source."
— Daniel Stewart, Co-Founder and CEO
Seed
$8.5M

The seed round was led by EQT Ventures with backing from several prominent tech investors.

"Today, we are going after humanity-defining problems, and hardware engineering teams are the ones working on complex projects like the development of various clean technologies. I call this group of engineers ‘new age hardware engineering teams’."
— Pari Singh, CEO and Founder